...
首页> 外文期刊>International journal of immunogenetics >Towards allele-level human leucocyte antigens genotyping - assessing two next-generation sequencing platforms: Ion Torrent Personal Genome Machine and Illumina MiSeq
【24h】

Towards allele-level human leucocyte antigens genotyping - assessing two next-generation sequencing platforms: Ion Torrent Personal Genome Machine and Illumina MiSeq

机译:进行等位基因水平的人类白细胞抗原基因分型-评估两个下一代测序平台:Ion Torrent Personal Genome Machine和Illumina MiSeq

获取原文
获取原文并翻译 | 示例
           

摘要

Human leucocyte antigens (HLA) typing has been a challenge due to extreme polymorphism of the HLA genes and limitations of the current technologies and protocols used for their characterization. Recently, next-generation sequencing techniques have been shown to be a well-suited technology for the complete characterization of the HLA genes. However, a comprehensive assessment of the different platforms for HLA typing, describing the limitations and advantages of each of them, has not been presented. We have compared the Ion Torrent Personal Genome Machine (PGM) and Illumina MiSeq, currently the two most frequently used platforms for diagnostic applications, for a number of metrics including total output, quality score per position across the reads and error rates after alignment which can all affect the accuracy of HLA genotyping. For this purpose, we have used one homozygous and three heterozygous well-characterized samples, at HLA-A, HLA-B, HLA-C, HLA-DRB1 and HLA-DQB1. The total output of bases produced by the MiSeq was higher, and they have higher quality scores and a lower overall error rate than the PGM. The MiSeq also has a higher fidelity when sequencing through homopolymer regions up to 9bp in length. The need to set phase between distant polymorphic sites was more readily achieved with MiSeq using paired-end sequencing of fragments that are longer than those obtained with PGM. Additionally, we have assessed the workflows of the different platforms for complexity of sample preparation, sequencer operation and turnaround time. The effects of data quality and quantity can impact the genotyping results; having an adequate amount of good quality data to analyse will be imperative for confident HLA genotyping. The overall turnaround time can be very comparable between the two platforms; however, the complexity of sample preparation is higher with PGM, while the actual sequencing time is longer with MiSeq.
机译:由于HLA基因的极端多态性以及用于表征其特征的当前技术和方案的局限性,人类白细胞抗原(HLA)的分型一直是一个挑战。近来,已证明下一代测序技术是用于完整表征HLA基因的一种合适技术。但是,尚未提供对HLA类型不同平台的全面评估,该评估描述了每种平台的局限性和优势。我们已经比较了目前两个最常用于诊断应用程序的离子激流型个人基因组机(PGM)和Illumina MiSeq,以评估许多指标,包括总输出,每个位置读取的质量得分以及对齐后的错误率。所有这些都会影响HLA基因分型的准确性。为此,我们在HLA-A,HLA-B,HLA-C,HLA-DRB1和HLA-DQB1中使用了一个纯合性和三个杂合性充分表征的样品。 MiSeq生产的碱基的总产量更高,并且质量分数和总体错误率均低于PGM。当通过长度不超过9bp的均聚物区域进行测序时,MiSeq也具有较高的保真度。使用MiSeq,使用比PGM更长的片段的成对末端测序,更容易实现在遥远的多态性位点之间设置相位的需要。此外,我们评估了不同平台的工作流程,以了解样品制备,测序仪操作和周转时间的复杂性。数据质量和数量的影响会影响基因分型的结果;拥有足够数量的高质量数据进行分析对于确保HLA基因分型至关重要。这两个平台之间的总周转时间非常相似。但是,使用PGM进行样品制备的复杂性更高,而使用MiSeq进行实际测序的时间则更长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号